Skip to main content
Log in

Occurrence of malignancy, collagen diseases and myasthenia gravis in the course of experimental infections with Candida albicans

  • Published:
Mycopathologia et mycologia applicata Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Bibliography

  1. Adams, R. D., Denny-Brown, D. &Pearson, C.: Diseases of Muscle. New York, Hoeber, 1953.

    Google Scholar 

  2. Allan, W.: Dermatomyositis or Scleroderma; Report of a Case. Arch. Derm. Syph.19 265–269, 1929.

    Google Scholar 

  3. Anderson, H. J., Churchil-Davidson, H. C. &Richardson, A. T.: Bronchial neoplasma with myasthenia: prolonged apnoe after administration of succinylcholine. Lancet2 1291–1293, 1953.

    Article  Google Scholar 

  4. Arkin, A.: A Clinical and pathological study of periarteritis nodosa: a report of five cases, on histologically healed. Amer. J. Path.6 401–426, 1930.

    Google Scholar 

  5. Arundel, F. D., Wilkinson, R. D. &Haserick, J. R.: Dermatomyositis and malignant neoplasms in adults. Arch. Derm.82 772–775, 1960.

    PubMed  Google Scholar 

  6. Bezecny, G. M.: Dermatomyositis. Dtsch. Arch. Derm. Syph.171 242–251, 1935.

    Google Scholar 

  7. Bickerstaff, E. R. &Woolf, A. L.: The intramuscular nerve endings in myasthenia gravis. Brain83 10–23, 1960.

    PubMed  Google Scholar 

  8. van Bogaert, L. &Radermecker, M. A.: De quelques affections musculaires primitives en dehors des myopathies. Etudes présentées à la lre Réunion Neurologique Belgo-Suisse; Edition des Acta neurol. psych. belg.,1, 1954.

  9. Bouttier, M. &Bertrand, I.: Etude anatomo-clinique d'un cas de maysthénie Erb-Goldflam. Ann. Méd.10 173–184, 1921.

    Google Scholar 

  10. Buzzard, E. F.: The clinical cases and postmortem examination of five cases of myasthenia gravis. Brain28 438–483, 1905.

    Google Scholar 

  11. Coers, C. &Desmedt, J. E.: Abnormal end-plates in myasthenic muscle. Lancet2 1124, 1958.

    Article  Google Scholar 

  12. Curtis, A. C., Blaylock, H. C. &Harrell, E. R.: Malignant lesions associated with dermatomyositis. J. A. M. A.150 844–846, 1952.

    Google Scholar 

  13. Dowling, G. B.: Scleroderma and dermatomyositis. Brit. J. Derm.67 275–290, 1955.

    PubMed  Google Scholar 

  14. Gullberg, E.: Some observations indicating the possibility of a relation of the bacillus Koch to a yeast-like fungus (of oidium type). Acta med. scand.94 527–566, 1938.

    Google Scholar 

  15. Harbitz, F.: Periarteritis nodosa. Bull. N. Y. Acad. Med.3 17–18, 1927.

    Google Scholar 

  16. Heathfield, K. W. G. &Williams, J. R. B.: Peripheral neuropathy and myopathy associated with bronchogenic carcinoma. Brain77 122–137, 1954.

    PubMed  Google Scholar 

  17. Hecht, M. S.: Dermatomyositis in childhood. J. Pediatr.17 791–800, 1940.

    Google Scholar 

  18. Henson, R. A., Russel, D. S. &Wilkinson, M.: Carcinomatous myopathy and myopathy. A clinical and pathological study. Brain77 82–121, 1954.

    PubMed  Google Scholar 

  19. Hollstrom, Einar.: An investigation into a yeast-like fungus isolated from patients suffering from, or suspected of, pulmonary tuberculosis. Uppsala: Almqvist and Wiksells Boktryckeri A.–B. 107 pages.

  20. Hueper, W. C.: Macromolecular substances as pathogenic agents. Arch. Path.33 267–290, 1942.

    Google Scholar 

  21. Kampmeier, R. H. &Shapiro, J. L.: Diffuse and sometimes recurrent course of diffuse arteritis; observation and report of a patient observed for twenty-one years. AMA Arch. intern. Med.92 856–879, 1953.

    PubMed  Google Scholar 

  22. Klingman, W. O.: Dermatomyositis resulting in scleroderma. Arch. Neurol. Psych.24: 1187–1198, 1930.

    Google Scholar 

  23. Lewis, T.: Notes on scleroderma (dermatomyositis). Brit. J. Derm. Syph.52 233–242, 1940.

    Google Scholar 

  24. Mankiewicz, E., Stackiewicz, E. &Litwak, M.: A Polysaccharide isolated fromCandida albicans as growth promoting factor for myobacterium tuberculosis. Canad. J. Microbiol.5 261–267, 1958.

    Google Scholar 

  25. Mankowski, Z. T. &Littleton, B. J.: Action of cortisone and ACTH on experimental fungus infections. Antibiot. Chemother., N. Y.4 253–258, 1954.

    Google Scholar 

  26. Mankowski, Z. T.: The influence of various sex hormones on experimental fungus infections. Antiobiot. Chemother., N. Y.4 1101–1104, 1954.

    Google Scholar 

  27. Mankowski, Z. T.: The influence of hormonal conditions on experimental fungus infection. In Sternber, T., and Newcomer, V.: Therapy of fungus diseases. Little Brown, Boston and Toronto, 90–99, 1955.

    Google Scholar 

  28. Mankowski, Z. T.: The experimental pathogenicity of various species ofCandida in Swiss mice. Trans. N. Y. Acad. Sci.19 548–570, 1957.

    PubMed  Google Scholar 

  29. Mankowski, Z. T.: The pathological activity of metabolic products ofCandida albicans on newborn mice. Mycopathol. et Mycol. Appl.17 165–175, 1962.

    Google Scholar 

  30. Mankowski, Z. T.: Occurrence of calcinosis in the course of experimental fungus infections. Sabouraudia,1 234–236, 1962.

    PubMed  Google Scholar 

  31. Mankowski, Z. T.: Pathological changes observed during experimentalCandidiasis. Ninth Int. Congr. Bot., Montreal, 1959 p. 250.

  32. McComb &MacMahon, H. E.: Dermatomyositis associated with metastazing bronchogenic carcinoma; a clinicopathological conference. Med. Clin. N. Amer.31 1148–1162, 1947.

    Google Scholar 

  33. McDermot, Violet: The changes in the motor end-plate in myasthenia gravis. Brain83 24–36, 1960.

    PubMed  Google Scholar 

  34. Mackenzie, I.: Bronchial neoplasma with myasthenia gravis. Lancet1 108–109, 1954.

    Article  Google Scholar 

  35. Mella, H.: Irradiation of the thymus in myasthenia gravis. Med. Clin. N. Amer.7 939–943, 1923.

    Google Scholar 

  36. Mendelow, H. &Genkins, G.: Studies in myasthenia gravis: cardiac and associated pathology. J. Mt. Sinai Hosp.21 218–225, 1954.

    Google Scholar 

  37. Nattras, F. J.: Discussion on polymyositis: clinical aspects. Proc. R. Soc. Med. Med.49 105–114, 1956.

    Google Scholar 

  38. Nixon, J. A.: Scleroderma and myositis. Lancet1 79–81, 1907.

    Article  Google Scholar 

  39. O'Leary, P. A. &Waisman, M. D.: A study of forty cases. Arch. Derm. Syph.41 1001–1019, 1940.

    Google Scholar 

  40. Pagel, W., Woolf, A. L. &Osher, R.: Histological observation on dermatomyositis. J. Path. Bact.61 403–411, 1949.

    Article  Google Scholar 

  41. Pearson, C. M. &Rose, A. S.: Myositis. Neuromuscular disorders. Res. Publ. Assoc. Nerv. Ment. Dis.XXXVIII, 422–478, 1961.

    Google Scholar 

  42. Ragan, C.: The effect of adrenotropic hormone (ACTH) (Armour) on the clinical syndrome of dermatomyositis. Proc. First Clinical ACTH conference, Philadelphia, The Blakistone Company, p. 423, 1950.

    Google Scholar 

  43. Rake, G.: On the pathology and pathogenesis of scleroderma. John. Hopkins Hosp. Bull.48 212–227, 1931.

    Google Scholar 

  44. Rantz, L. A., DiCapio, J. M. &Randall, E.: Antistreptolysin-O and antihyaluronidase titers in health and various diseases. Amer. J. med. Sos.224 194–200, 1952.

    Google Scholar 

  45. Reenstierna, J.: Sur la vie non acido-résistante des microorganisms de la tuberculose. Arch. Inst. Pasteur Tunis.15 309–317, 1926.

    Google Scholar 

  46. Rich, A. R.: The role of hypersensitivity in periarteritis nodosa as indicated by seven cases developing during serum sickness and sulfonamide therapy. Bull. Johns Hopkins Hosp.71 123–135, 1942.

    Google Scholar 

  47. Rich, A. R. &Gregory, J. E.: The experimental demonstration that periarteritis nodosa is a manifestation of hypersensitivity. Bull. Johns Hopkins Hosp.72 65–88, 1943.

    Google Scholar 

  48. Rothstein, J. L. &Welt, S. Calcinosis universalis and calcinosis circumscripta in infancy and in childhood. Amer. J. Dis. Child.52 368–422, 1936.

    Google Scholar 

  49. Rottino, Antonio: Myocardial lesions in myasthenia gravis. Arch. Path.34 557–561, 1942.

    Google Scholar 

  50. Rozenthal, C. &Hoffmann, H.: Ein Fall von Dermatomyositis mit Ausgang in Sklerodermie. Klin. Wschr.3 115–116, 1924.

    Article  Google Scholar 

  51. Russell, D. S.: Histological changes in the striped muscles in myasthenia gravis. J. Path. Bact.65 279–289, 1953.

    Article  PubMed  Google Scholar 

  52. Shilo: Nonspecific resistance to infections. Ann. Rev. Microbiol.13 225–278, 1959.

    Google Scholar 

  53. Talbott, J. H., Gall, E. A., Consolazio, W. V. &Coombs, F. S.: Dermatomyositis with scleroderma, calcinosis and renal endarteritis associated with focal cortical necrosis. Arch. intem. Med.63 476–496, 1939.

    Google Scholar 

  54. Walker, R. P.: Congenital myasthenia gravis. Amer. J. Dis. Child.86 198–200, 1953.

    Google Scholar 

  55. Walton, J. N., andAdams, R. D.: Polymyositis. E. & S. Livingstone, Ltd. Edinburgh and London, 1958.

    Google Scholar 

  56. Weigert, C.: Pathologisch-anatomischer Beitrag zur Erbschen Krankheit. Neurol. Cblt.20 597–601, 1901.

    Google Scholar 

  57. Unverricht: Polymyositis acuta progressiva. Z. klin. Med.12 533–549, 1887.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This paper was presented under the title “Chronic pathogenicity ofCandida albicans” at the Annual Meeting of American Mycological Society on August 28, 1961 at Lafayette, Indiana.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mankowski, Z.T. Occurrence of malignancy, collagen diseases and myasthenia gravis in the course of experimental infections with Candida albicans. Mycopathologia et Mycologia Applicata 19, 1–20 (1963). https://doi.org/10.1007/BF02049009

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02049009

Keywords

Navigation